In accordance with standard industry practice, BioRestorative plans to wait to provide investors with further updates on the Type B meeting until such time that it has received and reviewed the ...
Pierre Fabre Pharmaceuticals Inc. (PFP) announces the transfer of the Biologics License Application (BLA) for tabelecleucel ...
US biopharma firm Viridian Therapeutics today announced the successful submission of its biologics license application (BLA) to the US Food and Drug Administration (FDA) for veligrotug, the company’s ...
Savara advances BLA plans with strong molgramostim data, large aPAP market potential, and a reinforced cash position. Find ...
Q3 2025 Management View CEO Matthew Kapusta reported, "in the third quarter, we announced positive top line data from our ...
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...
The Barbados Licensing Authority (BLA) yesterday issued a statement in response to public claims made by one of the ...
Get the latest on Scholar Rock's regulatory strategy, financial outlook, and apitegromab launch plans for SMA.
Motorists in northern Barbados now have easier access to vehicle registration services, following the expansion of operations ...
Prescription Drug User Fee Act (PDUFA) goal date of December 31, 2025 ISELIN, N.J., (GLOBE NEWSWIRE) -- Outlook Therapeutics, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback